A study published in the Journal of Affective Disorders proposes a novel, fully automated artificial intelligence (AI) algorithm leveraging ExtraTrees (ET) forests to distinguish patients with major ...
Using a large multi-site dataset comprising 1,660 patients with major depressive disorder (MDD) and 1,340 healthy controls (HCs), researchers identified group-level differences in functional ...
Neumora Therapeutics (NMRA) has been able to establish an advanced phase 3 program, which is ultimately going to be composed of several late-stage studies. This is going to be the inclusion of three ...
Neumora Therapeutics, Inc. (NMRA) is gearing up to report results from one of its phase 3 studies, which is using its drug Navacaprant for the treatment of patients with major depressive disorder (MDD ...
BOSTON, March 11, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, and Sooma Medical, a world-leading provider of ...
An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback